Quest Diagnostics logo
Quest Diagnostics
DGX | NYSE
Chart Builder DCF Calculator
$262.21
+$2.61 (+1.01%)
At close: Nov 16, 2026, 4:00 PM ET
$261.25
-$0.96 (-0.37%)
After-hours: Nov 16, 2026, 7:29 PM ET

Quest Diagnostics Company Profile

Company profile explained

Company Profile

Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.

Key Executives

Name Position
James E. Davis Chairman, Chief Executive Officer & President
Sam A. Samad Executive Vice President & Chief Financial Officer
Catherine T. Doherty Executive Vice President of Regional Businesses
Damini Chokshi Vice President of Investor Relations
Dan Haemmerle Interim VP of Investor Relations & VP Finance
Garry Clark Senior Vice President and Chief Marketing & Communications Officer
Karthik Kuppusamy Senior Vice President of Clinical Solutions
Kristin Lee Wallace Senior Vice President & Chief Compliance Officer
Michael E. Prevoznik Senior Vice President & General Counsel
Michael J. Deppe Senior Vice President, Corporate Controller & Chief Accounting Officer
Murali Balakumar Senior Vice President and Chief Information & Digital Officer

Latest SEC Filings

Date Type Title
Oct 28, 2026 4 Filing
Oct 23, 2026 4 Filing
Oct 23, 2026 4 Filing
Oct 23, 2026 4 Filing
Oct 23, 2026 4 Filing
Oct 23, 2026 4 Filing
Oct 23, 2026 4 Filing
Oct 23, 2026 4 Filing
Oct 23, 2026 4 Filing
Oct 23, 2026 10-Q Quarterly Report
View All SEC Filings ➞
Quest Diagnostics
Quest Diagnostics logo
Country United States
IPO Date Dec 17, 1996
Industry Medical - Diagnostics & Research
Sector Healthcare
Employees 57,000
CEO James E. Davis

Contact Details

500 Plaza Drive Secaucus, New Jersey 07094 United States

Stock Details

Ticker Symbol DGX
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001022079
CUSIP Number 74834L100
ISIN Number US74834L1008
SIC Code 8071

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.